NM

Nayana Maheshkumar Dinnimath

Active Director Director DIN 11059809
DIN 11059809 First appointment Apr 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Nayana Maheshkumar Dinnimath

Data last updated:

Nayana Maheshkumar Dinnimath is a Director at Lucashine Pharma Private Limited (since 2025). The company operates in Pharma.

DIN 11059809
Primary Designation Director
Industry Pharma
First Appointment 17 Apr 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Lucashine Pharma Private Limited U46497KA2025PTC201413
Director17 Apr 20252025Active

Board colleagues of Nayana Maheshkumar Dinnimath

NameDINCompanyDesignation
Vani Dinnimath11059810Lucashine Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Lucashine Pharma Private Limited
Premium access

Shareholding and investment profile for Nayana Maheshkumar Dinnimath

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nayana Maheshkumar Dinnimath

Nayana Maheshkumar Dinnimath currently holds 1 directorship: Lucashine Pharma Private Limited (Director, since 17 Apr 2025).

Nayana Maheshkumar Dinnimath was first appointed on 17 Apr 2025 as Director at Lucashine Pharma Private Limited.

The current boards of Nayana Maheshkumar Dinnimath's companies include Vani Dinnimath (Lucashine Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available